Clinical Trial Update: Study of NGX-1998 for the Treatment of Postherpetic Neuralgia [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating NGX-1998 for postherpetic neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• NGX-1998

Snippet

Sponsor: NeurogesX | Conditions: Postherpetic Neuralgia, Pain | Phase 2 | Status: COMPLETED